[
    [
        {
            "time": "2021-10-15",
            "original_text": "See Why Emergent BioSolutions Stock Plunged 37% On Friday?",
            "features": {
                "keywords": [
                    "Emergent",
                    "BioSolutions",
                    "Stock",
                    "Plunged"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 9,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "Emergent Tanks as U.S. Ends Contract, Vaccine Maker Cuts Outlook",
            "features": {
                "keywords": [
                    "Emergent",
                    "Tanks",
                    "U.S.",
                    "Contract",
                    "Vaccine",
                    "Maker",
                    "Cuts",
                    "Outlook"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "Emergent Biosolutions shares tumble on news it will lose COVID vaccine production contract with govt",
            "features": {
                "keywords": [
                    "Emergent",
                    "Biosolutions",
                    "shares",
                    "tumble",
                    "COVID",
                    "vaccine",
                    "production",
                    "contract",
                    "govt"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "Coronavirus tally: Global cases of COVID-19 top 248.7 million and U.S. cancels Emergent BioSolutions vaccine deal",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Global",
                    "cases",
                    "COVID-19",
                    "U.S.",
                    "cancels",
                    "Emergent",
                    "BioSolutions",
                    "vaccine",
                    "deal"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "U.S. cancels multimillion dollar deal with Emergent BioSolutions, which produced contaminated J&J vaccines: report",
            "features": {
                "keywords": [
                    "U.S.",
                    "cancels",
                    "multimillion",
                    "dollar",
                    "deal",
                    "Emergent",
                    "BioSolutions",
                    "contaminated",
                    "J&J",
                    "vaccines"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock",
            "features": {
                "keywords": [
                    "Johnson",
                    "&",
                    "Johnson",
                    "Strong",
                    "Value",
                    "Stock"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-15",
            "original_text": "FATE's Q3 Loss Narrower Than Expected, Pipeline in Focus",
            "features": {
                "keywords": [
                    "FATE",
                    "Q3",
                    "Loss",
                    "Narrower",
                    "Expected",
                    "Pipeline",
                    "Focus"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]